Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A recruiting trial listed on ClinicalTrials.gov is evaluating whether PRAISE, a personalized obstructive sleep apnea treatment adherence model, helps patients follow physician-recommended positive airway pressure treatment. The title also identifies Alzheimer's disease biomarkers and cognition among Black participants as study topics; no results or peptide intervention are described.
- 01The study is recruiting participants.
- 02Researchers aim to assess PRAISE's effectiveness in supporting adherence to positive airway pressure treatment.
- 03The provided excerpt reports no findings and identifies no peptide intervention.
Why it matters Editorial
The study addresses sleep apnea treatment adherence and cognition, but the provided text establishes no direct connection to peptides.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.